3.12. Effects of the Introduction of WT-GSK-3β, KD-GSK-3β, and pLXSN on Sensitivity of MCF-7 Breast Cancer Cells to the Type-II Diabetes Drug Metformin and the Nutraceutical Berberine. This evidence concerns the gene GSK3B and breast cancer.